

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Tackling resistance: emerging antimalarials and new... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1170/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1170" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination" />
    
            <meta name="og:title" content="F1000Research Article: Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination.">
            <meta name="og:description" content="Read the latest article version by Emily S. Mathews, Audrey R. Odom John, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="16190">
            <meta name="article-id" content="14874">
            <meta name="dc.title" content="Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination">
            <meta name="dc.description" content="Malaria remains a significant contributor to global human mortality, and roughly half the world&rsquo;s population is at risk for infection with Plasmodium spp. parasites. Aggressive control measures have reduced the global prevalence of malaria significantly over the past decade. However, resistance to available antimalarials continues to spread, including resistance to the widely used artemisinin-based combination therapies. Novel antimalarial compounds and therapeutic targets are greatly needed. This review will briefly discuss several promising current antimalarial development projects, including artefenomel, ferroquine, cipargamin, SJ733, KAF156, MMV048, and tafenoquine. In addition, we describe recent large-scale genetic and resistance screens that have been instrumental in target discovery. Finally, we highlight new antimalarial targets, which include essential transporters and proteases. These emerging antimalarial compounds and therapeutic targets have the potential to overcome multi-drug resistance in ongoing efforts toward malaria elimination.">
            <meta name="dc.subject" content="Plasmodium, antimalarial, drug targets, drug discovery, resistance">
            <meta name="dc.creator" content="Mathews, Emily S.">
            <meta name="dc.creator" content="Odom John, Audrey R.">
            <meta name="dc.date" content="2018/08/01">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14874.1">
            <meta name="dc.source" content="F1000Research 2018 7:1170">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Plasmodium">
            <meta name="prism.keyword" content="antimalarial">
            <meta name="prism.keyword" content="drug targets">
            <meta name="prism.keyword" content="drug discovery">
            <meta name="prism.keyword" content="resistance">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/08/01">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1170">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14874.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1170">
            <meta name="citation_title" content="Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination">
            <meta name="citation_abstract" content="Malaria remains a significant contributor to global human mortality, and roughly half the world&rsquo;s population is at risk for infection with Plasmodium spp. parasites. Aggressive control measures have reduced the global prevalence of malaria significantly over the past decade. However, resistance to available antimalarials continues to spread, including resistance to the widely used artemisinin-based combination therapies. Novel antimalarial compounds and therapeutic targets are greatly needed. This review will briefly discuss several promising current antimalarial development projects, including artefenomel, ferroquine, cipargamin, SJ733, KAF156, MMV048, and tafenoquine. In addition, we describe recent large-scale genetic and resistance screens that have been instrumental in target discovery. Finally, we highlight new antimalarial targets, which include essential transporters and proteases. These emerging antimalarial compounds and therapeutic targets have the potential to overcome multi-drug resistance in ongoing efforts toward malaria elimination.">
            <meta name="citation_description" content="Malaria remains a significant contributor to global human mortality, and roughly half the world&rsquo;s population is at risk for infection with Plasmodium spp. parasites. Aggressive control measures have reduced the global prevalence of malaria significantly over the past decade. However, resistance to available antimalarials continues to spread, including resistance to the widely used artemisinin-based combination therapies. Novel antimalarial compounds and therapeutic targets are greatly needed. This review will briefly discuss several promising current antimalarial development projects, including artefenomel, ferroquine, cipargamin, SJ733, KAF156, MMV048, and tafenoquine. In addition, we describe recent large-scale genetic and resistance screens that have been instrumental in target discovery. Finally, we highlight new antimalarial targets, which include essential transporters and proteases. These emerging antimalarial compounds and therapeutic targets have the potential to overcome multi-drug resistance in ongoing efforts toward malaria elimination.">
            <meta name="citation_keywords" content="Plasmodium, antimalarial, drug targets, drug discovery, resistance">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Emily S. Mathews">
            <meta name="citation_author_institution" content="Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA">
            <meta name="citation_author" content="Audrey R. Odom John">
            <meta name="citation_author_institution" content="Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA">
            <meta name="citation_author_institution" content="Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA">
            <meta name="citation_publication_date" content="2018/08/01">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1170">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14874.1">
            <meta name="citation_firstpage" content="1170">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1170/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1170.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=16190 /> <input type=hidden id=articleId name=articleId value=14874 /> <input type=hidden id=xmlUrl value="/articles/7-1170/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1170-v1.xml"> <input type=hidden id=article_uuid value=48eadd62-9d39-4ddb-9854-5fe8cf2e6505 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14874.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14874.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1170"
  },
  "headline": "Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination",
  "datePublished": "2018-08-01T15:44:51",
  "dateModified": "2018-08-01T15:44:51",
  "author": [
    {
      "@type": "Person",
      "name": "Emily S. Mathews"
    },    {
      "@type": "Person",
      "name": "Audrey R. Odom John"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Malaria remains a significant contributor to global human mortality, and roughly half the world&rsquo;s population is at risk for infection with Plasmodium spp. parasites. Aggressive control measures have reduced the global prevalence of malaria significantly over the past decade. However, resistance to available antimalarials continues to spread, including resistance to the widely used artemisinin-based combination therapies. Novel antimalarial compounds and therapeutic targets are greatly needed. This review will briefly discuss several promising current antimalarial development projects, including artefenomel, ferroquine, cipargamin, SJ733, KAF156, MMV048, and tafenoquine. In addition, we describe recent large-scale genetic and resistance screens that have been instrumental in target discovery. Finally, we highlight new antimalarial targets, which include essential transporters and proteases. These emerging antimalarial compounds and therapeutic targets have the potential to overcome multi-drug resistance in ongoing efforts toward malaria elimination."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1170/v1",
            "name": "Tackling resistance: emerging antimalarials and new parasite targets..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Tackling resistance: emerging antimalarials and new parasite targets... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=16190 data-id=14874 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14874.1" data-recommended="" data-doi="10.12688/f1000research.14874.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1170/v1/pdf?article_uuid=48eadd62-9d39-4ddb-9854-5fe8cf2e6505" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14874-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14874-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14874-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Mathews ES and Odom John AR. Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1170 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14874.1" target=_blank>https://doi.org/10.12688/f1000research.14874.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14874-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14874 id=track-article-signin-14874 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14874?target=/articles/7-1170/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16190 /> <input name=articleId type=hidden value=14874 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Emily S. Mathews<a href="https://orcid.org/0000-0001-7723-4428" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7723-4428</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:aodom@wustl.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Audrey R. Odom John</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Emily S. Mathews<a href="http://orcid.org/0000-0001-7723-4428" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7723-4428</div><sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:aodom@wustl.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Audrey R. Odom John</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 01 Aug 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14874.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA<br/> <sup>2</sup> Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA<br/> <p> <div class=margin-bottom> Emily S. Mathews <br/> <span>Roles: </span> Visualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Audrey R. Odom John <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=37156-36507></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=37157-36508></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Malaria remains a significant contributor to global human mortality, and roughly half the worlds population is at risk for infection with <i>Plasmodium </i>spp. parasites. Aggressive control measures have reduced the global prevalence of malaria significantly over the past decade. However, resistance to available antimalarials continues to spread, including resistance to the widely used artemisinin-based combination therapies. Novel antimalarial compounds and therapeutic targets are greatly needed. This review will briefly discuss several promising current antimalarial development projects, including artefenomel, ferroquine, cipargamin, SJ733, KAF156, MMV048, and tafenoquine. In addition, we describe recent large-scale genetic and resistance screens that have been instrumental in target discovery. Finally, we highlight new antimalarial targets, which include essential transporters and proteases. These emerging antimalarial compounds and therapeutic targets have the potential to overcome multi-drug resistance in ongoing efforts toward malaria elimination. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Plasmodium, antimalarial, drug targets, drug discovery, resistance </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Audrey R. Odom John (<a href="mailto:aodom@wustl.edu">aodom@wustl.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Audrey R. Odom John </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by the National Institutes of Health (R01AI103280 and R21AI123808-01 to Audrey Odom John and T32AI007172-37 to Emily Mathews), the Childrens Discovery Institute of Washington University and St. Louis Childrens Hospital (Audrey Odom John), and the Burroughs Wellcome Fund (to Audrey Odom John). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Mathews ES and Odom John AR. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Mathews ES and Odom John AR. Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1170 (<a href="https://doi.org/10.12688/f1000research.14874.1" target=_blank>https://doi.org/10.12688/f1000research.14874.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 01 Aug 2018, <b>7</b>(F1000 Faculty Rev):1170 (<a href="https://doi.org/10.12688/f1000research.14874.1" target=_blank>https://doi.org/10.12688/f1000research.14874.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 01 Aug 2018, <b>7</b>(F1000 Faculty Rev):1170 (<a href="https://doi.org/10.12688/f1000research.14874.1" target=_blank>https://doi.org/10.12688/f1000research.14874.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d18488e171>Introduction</h2><p class="" id=d18488e174>Malaria has posed a risk to human life since the origin of our species. Despite this long history, it was not until 1880 that French army surgeon Charles Louis Alphonse Laveran discovered intraerythrocytic parasites in the blood of a patient with malaria<sup><a href="#ref-1">1</a></sup>. Immediately following Laverans discovery, crucial aspects of this infection, including species classification and the details of the humanmosquito transmission cycle, were revealed<sup><a href="#ref-2">2</a><a href="#ref-6">6</a></sup>. These early studies shaped our understanding of the protozoan parasites of genus <i>Plasmodium</i> that cause malaria. In the complex life-cycle of <i>Plasmodium</i> spp., human infection begins with the bloodmeal of a female <i>Anopheles</i> mosquito. Parasites migrate to the liver, where they undergo a large, asymptomatic expansion, emerging to invade red blood cells and initiate asexual replication. A small fraction of these blood-stage parasites terminally differentiate into gametocytes that are taken up by the mosquito to complete sexual replication and begin the infection cycle anew. Five different species of <i>Plasmodium</i> cause the majority of human malaria: <i>P. falciparum</i>, <i>P. knowlesi</i>, <i>P. malariae</i>, <i>P. ovale</i>, and <i>P. vivax</i>. Malaria still accounts for an estimated 445,000 deaths and 216 million cases annually, and the majority of deaths result from infection with <i>P. falciparum</i><sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d18488e223>Malaria deaths have declined in large part because of the development of effective antimalarial medicines. Beginning in the late 1940s, chloroquine was the standard treatment for uncomplicated malaria<sup><a href="#ref-8">8</a></sup>. However, by the late 1950s and early 1960s, chloroquine-resistant <i>P. falciparum</i> was observed throughout Southeast Asia, Oceania, and South America. Resistance to chloroquine has since spread to nearly all areas of the world<sup><a href="#ref-9">9</a></sup>. Subsequent resistance has developed to antimalarials such as sulfadoxine/pyrimethamine, mefloquine, halofantrine, and quinine<sup><a href="#ref-10">10</a></sup>. Most recently, resistance to artemisinin-based combination therapies emerged in 2008 in parts of Southeast Asia and continues to spread<sup><a href="#ref-11">11</a><a href="#ref-19">19</a></sup>. Clinical artemisinin resistance manifests as a delayed clearance phenotype; that is, infection eventually resolves with treatment with artemisinin-based combination therapy, but the time required for parasite clearance substantially increases<sup><a href="#ref-14">14</a>,<a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. This delayed clearance could contribute to the even more troubling rise in multi-drug resistance, as parasites have gained both reduced artemisinin sensitivity<sup><a href="#ref-22">22</a></sup> and resistance against partner drugs, such as piperaquine<sup><a href="#ref-12">12</a>,<a href="#ref-19">19</a></sup>. As multi-drug resistance spreads, there is an urgent need for new antimalarial agents to control malaria infections. Optimally, new antimalarials will overcome multi-drug resistance, will be highly safe for use in vulnerable populations (such as infants and pregnant women), and will target more than one life-cycle stage in order to break the cycle of transmission. In this brief review, we highlight promising novel antimalarials currently in development and introduce emerging drug targets that may be key to ongoing efforts to eliminate malaria worldwide.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18488e273>Promising new antimalarials in development</h2><p class="" id=d18488e276>Global efforts to end malaria have led to the development of promising compounds. At the forefront of antimalarial development is the Medicines for Malaria Venture (MMV), which was established in 1999 as a not-for-profit, publicprivate partnership. The current MMV portfolio contains many promising compounds at various stages of development (research, translational, product development, and access; <a target=xrefwindow href="https://www.mmv.org/research-development/mmv-supported-projects" id=d18488e278>https://www.mmv.org/research-development/mmv-supported-projects</a>). To illustrate the diversity of the current portfolio, a selection of the emerging antimalarials currently in development is discussed below (<a href="#T1">Table 1</a>)<sup><a href="#ref-23">23</a><a href="#ref-29">29</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Selected promising antimalarial compounds.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d18488e303 class=n-a></a><thead><a name=d18488e305 class=n-a></a><tr><a name=d18488e307 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d18488e309 class=n-a></a>Antimalarial<br class=br>compound</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18488e314 class=n-a></a>Alternative<br class=br>names</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18488e319 class=n-a></a>Protein target/predicted<br class=br>target</th><th align=left colspan=1 rowspan=1 valign=top><a name=d18488e324 class=n-a></a>Target candidate profiles<sup><a href="#FN2">a</a></sup></th><th align=left colspan=1 rowspan=1 valign=top><a name=d18488e330 class=n-a></a>Current status in MMV pipeline<sup><a href="#FN3">b</a></sup></th></tr></thead><tbody><a name=d18488e338 class=n-a></a><tr><a name=d18488e340 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e342 class=n-a></a>Artefenomel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e345 class=n-a></a>OZ439</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e348 class=n-a></a>Unknown</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e351 class=n-a></a>Asexual parasite clearance;<br class=br>transmission blocking</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e356 class=n-a></a>Combined artefenomelferroquine is<br class=br>in the patient-exploratory stage</td></tr><tr><a name=d18488e362 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e364 class=n-a></a>Cipargamin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e367 class=n-a></a>KAE609,<br class=br>NITD609</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e372 class=n-a></a> <i>Pf</i>ATP4, based on resistance<br class=br>screen mutations<sup><a href="#ref-23">23</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e383 class=n-a></a>Asexual parasite clearance;<br class=br>transmission blocking</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e388 class=n-a></a>Patient-exploratory stage</td></tr><tr><a name=d18488e392 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e394 class=n-a></a>DSM265</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e397 class=n-a></a>Not applicable</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e400 class=n-a></a> <i>Plasmodium</i> DHODH<sup><a href="#ref-24">24</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e409 class=n-a></a>Asexual parasite clearance;<br class=br>targeting liver schizonts</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e414 class=n-a></a>Patient-exploratory stage</td></tr><tr><a name=d18488e418 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e420 class=n-a></a>Ferroquine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e423 class=n-a></a>SSR97193</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e426 class=n-a></a>Unknown</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e429 class=n-a></a>Asexual parasite clearance;<br class=br>transmission blocking</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e434 class=n-a></a>Combined artefenomelferroquine is<br class=br>in the patient-exploratory stage</td></tr><tr><a name=d18488e440 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e442 class=n-a></a>KAF156</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e445 class=n-a></a>GNF156</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e448 class=n-a></a> <i>Pf</i>CARL<sup><a href="#ref-25">25</a></sup>, <i>Pf</i>ACT, and <i>Pf</i>UGT<sup><a href="#ref-26">26</a></sup>,<br class=br>based on resistance screen<br class=br>mutations</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e473 class=n-a></a>Asexual parasite clearance;<br class=br>transmission blocking;<br class=br>targeting liver schizonts</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e480 class=n-a></a>Combined KAF156lumefantrine is in<br class=br>the patient-exploratory stage</td></tr><tr><a name=d18488e487 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e489 class=n-a></a>MMV048</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e492 class=n-a></a>MMV390048</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e495 class=n-a></a> <i>Plasmodium</i> PI4K<sup><a href="#ref-27">27</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e504 class=n-a></a>Asexual parasite clearance;<br class=br>transmission blocking;<br class=br>targeting liver schizonts</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e511 class=n-a></a>Patient-exploratory stage</td></tr><tr><a name=d18488e515 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e517 class=n-a></a>SJ733</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e520 class=n-a></a>(+)-SJ000557733</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e523 class=n-a></a> <i>Pf</i>ATP4, based on resistance<br class=br>screen mutations<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e537 class=n-a></a>Asexual parasite clearance;<br class=br>transmission blocking</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e542 class=n-a></a>Human volunteer stage</td></tr><tr><a name=d18488e546 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e548 class=n-a></a>Tafenoquine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e551 class=n-a></a>WR 238605,<br class=br>Etaquine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e556 class=n-a></a>Unknown</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e559 class=n-a></a>Targeting <i>Plasmodium</i><br class=br>hypnozoites</td><td align=left colspan=1 rowspan=1 valign=top><a name=d18488e566 class=n-a></a>Regulatory review stage</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=FN1 class=n-a></a><p id=d18488e576> DHODH, dihydroorotate dehydrogenase</p><p id=d18488e579>PI4K, phosphatidylinositol 4-kinase</p></div><div class=footnote><a name=FN2 class=n-a></a><p id=d18488e585> <sup>a</sup>According to Medicines for Malaria Venture (MMV) Target Candidate Profile classification.</p></div><div class=footnote><a name=FN3 class=n-a></a><p id=d18488e593> <sup>b</sup>Status as of 31 July 2018.</p></div></div></div><div class=section><a name=d18488e601 class=n-a></a><h3 class=section-title>Artefenomel and ferroquine</h3><p class="" id=d18488e606>The current standard of care for malaria is combination therapy based on artemisinin, which is highly valued as a potent, rapidly active antiparasitic compound. Like artemisinin, synthetic ozonides contain an endoperoxide bond. A first-generation ozonide, arterolane (OZ277), has already been licensed for clinical use in India as a combination therapy with piperaquine. However, concern has arisen that there may be a loss of potency against kelch13 mutant parasites, which are artemisinin resistant<sup><a href="#ref-30">30</a><a href="#ref-33">33</a></sup>. Other synthetic ozonides, including artefenomel (OZ439), have been developed<sup><a href="#ref-34">34</a></sup>. Artefenomel displays activity in transmission-blocking assays <i>in vitro</i><sup><a href="#ref-35">35</a></sup>, and clinical studies support its use in a single-exposure combination therapy<sup><a href="#ref-36">36</a></sup>. Unlike artemisinins peroxide bond, artefenomels peroxide bond is more stable and has an improved half-life in plasma: 23 hours compared with 0.5 hours<sup><a href="#ref-34">34</a></sup>. Promisingly, artemisinin-resistant mutants do not appear to be cross-resistant to artefenomel<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>, although some mutations in kelch13 may lead to partial cross-resistance<sup><a href="#ref-30">30</a><a href="#ref-33">33</a></sup>. Together, these properties support the continued efforts toward development and licensure of artefenomel for clinical use.</p><p class="" id=d18488e649>Ferroquine is a third-generation 4-aminoquinoline and a derivative of the antimalarial chloroquine. Although chloroquine resistance has spread to nearly all areas of the world, ferroquine efficacy is not impeded by chloroquine resistance mechanisms and resistance selection has not been observed in the laboratory<sup><a href="#ref-37">37</a></sup>. Ferroquine also retains activity against parasites resistant to chloroquine, mefloquine, quinine, and piperaquine<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. An initial clinical study with ferroquine in combination with artesunate showed a high malaria cure rate, and treatment with ferroquine also displayed post-treatment prophylaxis activity for at least 2 months<sup><a href="#ref-40">40</a></sup>. Recent phase 2 trials replaced artesunate with the more effective artefenomel<sup><a href="#ref-40">40</a><a href="#ref-42">42</a></sup>, and a combination of artefenomel and ferroquine therapy is in the patient-exploratory stage of the MMV portfolio.</p></div><div class=section><a name=d18488e675 class=n-a></a><h3 class=section-title>DSM265</h3><p class="" id=d18488e680> <i>Plasmodium</i> spp. depend on <i>de novo</i> pyrimidine synthesis because they lack pyrimidine salvage enzymes. An essential enzyme in the pyrimidine biosynthesis pathway is dihydroorotate dehydrogenase (DHODH). Large high-throughput screens were conducted to identify <i>Pf</i>DHODH inhibitors<sup><a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. These screens identified several classes of molecules that target DHODH, such as triazolopyrimidines, phenylbenzamides, ureas, and naphthamides<sup><a href="#ref-44">44</a></sup>. One triazolopyrimidine that has potent activity against asexual and liver-stage parasites is DSM265<sup><a href="#ref-45">45</a></sup>. DSM265 selectively inhibits <i>Plasmodium</i> spp. DHODH enzymes over human orthologues<sup><a href="#ref-24">24</a></sup>. DSM265 is currently in the patient-exploratory stage of the MMV pipeline and exhibits promising single-dose efficacy. Interestingly, DSM265 is predicted to remain at therapeutic concentrations in humans for more than a week after a single dose because of its favorable pharmacokinetic properties<sup><a href="#ref-45">45</a></sup>. DSM265 also has promising prophylactic activity, providing some protection against infection with a single dose up to 7 days before parasite challenge<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. The single-dose efficacy of DSM265 makes it exceptionally promising for both prophylaxis and treatment of disease. Furthermore, the potency of DSM265 supports future development of compounds that target <i>Plasmodium</i> DHODH.</p></div><div class=section><a name=d18488e731 class=n-a></a><h3 class=section-title>Cipargamin and SJ733</h3><p class="" id=d18488e736>Cipargamin (KAE609), a spiroindolone, also has potent activity against blood-stage malaria parasites<sup><a href="#ref-23">23</a>,<a href="#ref-48">48</a></sup>. A recent phase 2 study used once-daily dosing of cipargamin for 3 days on 21 adults with either uncomplicated <i>P. vivax</i> or <i>P. falciparum</i> malaria<sup><a href="#ref-49">49</a></sup>. Parasite clearance rates in this clinical study and <i>in vitro</i> are among the fastest of any antimalarial yet characterized<sup><a href="#ref-23">23</a>,<a href="#ref-49">49</a></sup>. Cipargamin likely targets the P-type Na<sup>+</sup> ATPase, <i>Pf</i>ATP4, because resistance mutations have emerged<sup><a href="#ref-23">23</a></sup>. <i>Pf</i>ATP4 appears to regulate parasite ion homeostasis, which is essential for survival, through active Na<sup>+</sup> export<sup><a href="#ref-50">50</a></sup>. Inhibition of <i>Pf</i>ATP4, through cipargamin treatment, perturbs ion homeostasis in the parasite and increases host cell membrane rigidity, resulting in blocked blood-stage development and transmission to mosquitoes<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a>,<a href="#ref-50">50</a><a href="#ref-52">52</a></sup>. Cipargamin is currently in the patient-exploratory stage of the MMV portfolio; however, it is not the only <i>Pf</i>ATP4 inhibitor currently in development. A diverse range of compounds, including spiroindolones<sup><a href="#ref-23">23</a>,<a href="#ref-51">51</a>,<a href="#ref-53">53</a></sup>, pyrazoleamides<sup><a href="#ref-29">29</a></sup>, aminopyrazoles<sup><a href="#ref-53">53</a></sup>, dihydroisoquinolones<sup><a href="#ref-28">28</a></sup>, and other compounds<sup><a href="#ref-54">54</a></sup>, have been shown to target <i>Pf</i>ATP4. A dihydroisoquinolone that likely targets <i>Pf</i>ATP4, SJ733, is in the human volunteer stage of the MMV portfolio. Resistance selection with SJ733, like cipargamin, has generated point mutations, some unique to SJ733 and not induced by cipargamin, in the <i>pfatp4</i> gene<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>. The antimalarial properties of <i>Pf</i>ATP4 inhibitors, such as cipargamin and SJ733, are exceptionally promising and support future development of compounds with this mechanism of action.</p></div><div class=section><a name=d18488e855 class=n-a></a><h3 class=section-title>KAF156</h3><p class="" id=d18488e860>A novel class of antimalarials, imidazolopiperazines, has recently emerged and been found to have potent asexual blood-stage and liver-stage activity<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. One such imidazolopiperazine, KAF156, is currently in the patient-exploratory stage of the MMV portfolio in combination with lumefantrine. Lumefantrine is a clinically approved partner agent; however, it has been modified to a new once-daily formulation for use with KAF156. In addition to displaying asexual blood- and liver-stage activity, KAF156 also inhibits the growth of sexual blood-stage parasites, including mature gametocytes<sup><a href="#ref-57">57</a></sup>. Therefore, KAF156 may be effective in preventing parasite transmission from humans to mosquitoes. The antimalarial mechanism of KAF156 is still unclear because resistance <i>in vitro</i> is thought to be indirectly mediated through mutation of <i>pfcarl</i>, <i>pfact</i>, and <i>pfugt</i>, which encode a conserved protein of unknown function, an acetyl-CoA transporter, and a UDP-galactose transporter, respectively<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-55">55</a></sup>. Future studies may illuminate the parasiticidal mechanism of imidazolopiperazines, but this class of drugs has great potential in the treatment of acute disease and reduction of parasite transmission.</p></div><div class=section><a name=d18488e898 class=n-a></a><h3 class=section-title>MMV048</h3><p class="" id=d18488e903>Another novel chemical class of antimalarials, 2-aminopyridines, was identified to have potent single-dose activity against <i>in vitro P. falciparum</i> and <i>in vivo P. berghei</i><sup><a href="#ref-58">58</a></sup>. From this initial screen of 2-aminopyridines, compound 15 (now known as MMV048) was identified with robust antimalarial activity. A follow-up study with MMV048 replicated the potent <i>in vitro</i> and <i>in vivo</i> activity of asexual blood-stage malaria parasites and also confirmed transmission-blocking and liver-stage activity<sup><a href="#ref-27">27</a></sup>. Genomic and chemoproteomic approaches identified <i>Plasmodium</i> phosphatidylinositol 4-kinase (PI4K) as the likely target of MMV048<sup><a href="#ref-27">27</a></sup>. PI4K functions in membrane trafficking and membrane assembly during asexual blood-stages<sup><a href="#ref-59">59</a></sup>. <i>Pf</i>PI4K is likely essential during the asexual blood-stage because attempts to insert an early stop codon were unsuccessful<sup><a href="#ref-59">59</a></sup>. The multi-stage antimalarial activity, prolonged half-life, and single-dose efficacy of MMV048 make it a promising new antimalarial in the patient-exploratory stage of the MMV pipeline.</p></div><div class=section><a name=d18488e945 class=n-a></a><h3 class=section-title>Tafenoquine</h3><p class="" id=d18488e950>Although infection with <i>P. falciparum</i> represents the largest burden of malaria deaths, there is also a need to develop medicines that prevent the relapse of <i>P. vivax</i> and <i>P. ovale</i>. Unlike <i>P. falciparum</i>, both <i>P. vivax</i> and <i>P. ovale</i> have a dormant liver-stage form called a hypnozoite. Hypnozoites can reactivate without warning, leading to the onset of malarial symptoms. This dormant stage remains both a challenge to treat and a potent barrier to malaria elimination. Tafenoquine, an 8-aminoquinoline, is currently under development for the prevention of <i>P. vivax</i> relapse. Tafenoquine has high activity as a single-dose treatment and has promising anti-hypnozoite activity in humans<sup><a href="#ref-60">60</a></sup>. However, tafenoquine has therapeutic restrictions similar to those of the current radical cure standard for <i>P. vivax</i> and <i>P. ovale</i>, primaquine, which might limit its therapeutic impact. Both primaquine and tafenoquine cause dose-dependent acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase deficiency<sup><a href="#ref-61">61</a>,<a href="#ref-62">62</a></sup>. Because of its longer half-life, tafenoquine requires a higher glucose-6-phosphate dehydrogenase activity threshold than primaquine; thus, a greater proportion of individuals will be ineligible for tafenoquine treatment and primaquine will still be needed<sup><a href="#ref-63">63</a></sup>. In July 2018, the US Food and Drug Administration approved tafenoquine under the trade name Krintafel. Tafenoquine is the first new antimalarial in 60 years to prevent relapse of <i>P. vivax.</i> However, its limitations highlight the need for development of additional compounds that target relapsing malaria.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18488e1004>Emerging new antimalarial targets</h2><p class="" id=d18488e1007>Continued efforts to dissect the basic biology of the complex malarial organism have yielded new therapeutic targets for the development of antimalarials. The <i>Plasmodium</i> Genetic Modification Project (<i>Plasmo</i>GEM) (<a target=xrefwindow href="http://plasmogem.sanger.ac.uk" id=d18488e1015>http://plasmogem.sanger.ac.uk</a>), a not-for-profit, open-access research resource, has advanced our understanding of <i>Plasmodium</i> by providing vectors for genome-wide manipulation. <i>Plasmo</i>GEM contains over 2,000 plasmids designed to tag or delete genes in <i>P. berghei</i><sup><a href="#ref-64">64</a></sup>. Provided without cost, these tools have been used in a recent large-scale knockout screen to identify essential genes. The essentiality of over 50% of the genome was tested in an <i>in vivo</i> mouse model of <i>P. berghei</i> infection<sup><a href="#ref-65">65</a></sup>. Surprisingly, 44.9% of genes were found to be essential and an additional 18% showed reduced parasite blood-stage growth; therefore, 62.9% of genes are required in <i>P. berghei</i> for normal asexual growth<sup><a href="#ref-65">65</a></sup>. The high percentage of essential genes and low functional redundancy suggest that <i>Plasmodium</i> may have considerably more drug targets than do bacteria, for example<sup><a href="#ref-65">65</a></sup>. This genetic screen resulted in the identification of essential cellular processes in the parasite. Specific examples of pathways enriched with essential genes include glycosylphosphatidylinositol anchor biosynthesis, the mitochondrial tricarboxylic acid cycle, ubiquinone biosynthesis, and isoprenoid biosynthesis<sup><a href="#ref-65">65</a></sup>. From this genetic screen, a searchable phenotype database was built (<a target=xrefwindow href="http://plasmogem.sanger.ac.uk/phenotypes" id=d18488e1060>http://plasmogem.sanger.ac.uk/phenotypes</a>).</p><p class="" id=d18488e1064>A large forward genetic screen in <i>P. falciparum</i> parasites recently identified more than 2,680 genes that are likely essential for asexual blood-stage growth<sup><a href="#ref-66">66</a></sup>. When high-throughput <i>piggyBac</i> transposon insertional mutagenesis was used in combination with quantitative insertion site sequencing<sup><a href="#ref-67">67</a>,<a href="#ref-68">68</a></sup>, the mutability and fitness cost of 5,399 genes were evaluated<sup><a href="#ref-66">66</a></sup>. The AT-richness of the <i>P. falciparum</i> genome (&gt;81%) is well suited for <i>piggyBac</i> transposon-based mutagenesis because of the high density of the tetranucleotide insertion target sequence TTAA<sup><a href="#ref-66">66</a></sup>. To quantify gene essentiality, a mutagenesis index score and mutagenesis fitness score were calculated for each locus. Together, these two independent measures were used to classify a gene as likely essential or dispensable, and this methodology may be expanded to identify essential genes for other life-cycle stages<sup><a href="#ref-66">66</a></sup>. The essential genes and pathways discovered in both the <i>Plasmo</i>GEM <i>P. berghei</i> screen<sup><a href="#ref-65">65</a></sup> and <i>piggyBac</i> transposon <i>P. falciparum</i> screen<sup><a href="#ref-66">66</a></sup> will supplement ongoing studies and likely initiate investigation into novel putative antimalarial targets.</p><p class="" id=d18488e1124>A final strategy to identify possible new antimalarial targets is the resistance screen. Resistance screens challenge the malaria parasite with low levels of an antimalarial compound to hinder development. This can lead to <i>in vitro</i> evolution and selection for resistance mutations that relieve growth suppression. Therefore, resistance screens can be used to discover both mediators of drug resistance and novel antimalarial drug targets<sup><a href="#ref-22">22</a>,<a href="#ref-69">69</a></sup>. Winzeler and colleagues recently performed a large resistance screen with 37 distinct compounds<sup><a href="#ref-70">70</a></sup>. Whole genome sequencing of 262 compound-resistant parasite lines identified several candidate resistance mutations. Although the screen confirmed previously identified multi-drug resistance mechanisms and illuminated new drug targetinhibitor pairs, only two novel drug-resistance genes<i>pfabcI3</i> and <i>pfaat1</i><sup><a href="#ref-70">70</a></sup>were identified. Below, we highlight a few emerging antimalarial targets of particular promise (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/16190/d60ca416-893b-4179-90e6-c3b353fd31a0_figure1.gif"><img alt="d60ca416-893b-4179-90e6-c3b353fd31a0_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/16190/d60ca416-893b-4179-90e6-c3b353fd31a0_figure1.gif"></a><div class=caption><h3>Figure 1. Localization of antimalarial targets in the asexual parasite.</h3><p id=d18488e1164>Shown are parasite organelles, including the nucleus, apicoplast (AP), endoplasmic reticulum (ER), food vacuole (FV), rhoptries (RH), exonemes, and vesicles. The intraerythrocytic parasite is located within the parasitophorous vacuole (PV), which is delineated by the PV membrane (PVM), where both SUB1 and SERA6 are found during egress<sup><a href="#ref-98">98</a></sup>. Rab11a likely localizes to vesicles, which it guides to target membranes. In the invading parasite, plasmepsin IX (PMIX) is found in the bulbs of RH and plasmepsin X (PMX) localizes to exonemes<sup><a href="#ref-72">72</a></sup>.</p></div></div><div class=section><a name=d18488e1180 class=n-a></a><h3 class=section-title>PMIX and PMX</h3><p class="" id=d18488e1185>Two recent studies highlighted the importance of plasmepsins IX (PMIX) and X (PMX) for parasite development<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>. Plasmepsins comprise a family of 10 aspartic proteases in the <i>P. falciparum</i> genome. A number of studies have focused on the digestive vacuole plasmepsins I to IV (PMI to PMIV), including development of chemical inhibitors<sup><a href="#ref-73">73</a><a href="#ref-76">76</a></sup>. Subsequent functional genetic studies of PMIPMIV revealed that they are not essential for parasite survival<sup><a href="#ref-77">77</a></sup>. PMIX and PMX are expressed in asexual blood-stage parasites<sup><a href="#ref-78">78</a></sup>. Conditional knockdown of PMIX in <i>P. falciparum</i> revealed that it is essential for red blood cell invasion<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>. PMX knockdown similarly interrupted red blood cell invasion but also revealed an additional requirement of PMX in red blood cell egress<sup><a href="#ref-72">72</a></sup>. A recent study employed a combination of <i>in vitro</i> and <i>in vivo</i> rodent experiments to find that hydroxyl-ethyl-amine-based scaffold compound 49c (referred to as 49c) inhibits both PMIX and PMX<sup><a href="#ref-71">71</a></sup>. 49c is an effective inhibitor against <i>P. falciparum in vitro</i> and the rodent parasite <i>Plasmodium berghei in vivo</i><sup><a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>. Treatment with 49c inhibits asexual, sexual, and liver-stage development, indicating that 49c or other PMIX or PMX inhibitors may have value to both treat symptomatic malaria and block transmission<sup><a href="#ref-71">71</a></sup>. Together, these observations provide compelling evidence that PMIX and PMX are promising targets for antimalarial development.</p></div><div class=section><a name=d18488e1256 class=n-a></a><h3 class=section-title>Rab11a</h3><p class="" id=d18488e1261>In the recent <i>P. berghei</i> functional genetic screen, one of the cellular pathways most enriched with essential genes is that of isoprenoid biosynthesis<sup><a href="#ref-65">65</a></sup>. A number of studies have previously highlighted the requirement of isoprenoid biosynthesis for <i>P. falciparum</i> asexual replication<sup><a href="#ref-81">81</a><a href="#ref-83">83</a></sup>. Isoprenoids are necessary for protein prenylation, the post-translational lipid modification of proteins. Because chemical inhibition of protein prenylation in the malaria parasite disrupts asexual parasite growth<sup><a href="#ref-84">84</a><a href="#ref-90">90</a></sup>, prenylated malarial proteins are potential antimalarial targets. Recent chemical labeling approaches have revealed that only 15 to 19 proteins are prenylated in blood-stage malaria and a majority of these proteins are Rab GTPases<sup><a href="#ref-91">91</a>,<a href="#ref-92">92</a></sup>. Rab GTPases function in docking vesicles to membranes and their prenylation aids in association with target membranes<sup><a href="#ref-93">93</a></sup>. Rab11a, a Rab GTPase, is expressed and prenylated in asexual blood-stage malaria parasites<sup><a href="#ref-91">91</a>,<a href="#ref-92">92</a>,<a href="#ref-94">94</a></sup> and is essential for asexual parasite replication<sup><a href="#ref-95">95</a></sup>. In the parasite, Rab11a functions as a mediator of PI4K signaling and is a binding partner of PI4K, the target of imidazopyrazines and MMV048<sup><a href="#ref-27">27</a>,<a href="#ref-59">59</a>,<a href="#ref-96">96</a></sup>. Mutation of Rab11a confers resistance to the imidazopyrazine, KAI715<sup><a href="#ref-59">59</a></sup>. Interestingly, Rab11a has very low genetic diversity when sequenced in 2,000 <i>Plasmodium</i> clinical isolates, and only one non-synonymous mutation has been identified<sup><a href="#ref-97">97</a></sup>. These features suggest that Rab11a may represent a promising target because of both its prenylation and interactions with essential signaling pathways within the parasite. Additional studies are needed to evaluate the biological roles of the remaining prenylated proteins in blood-stage malaria.</p></div><div class=section><a name=d18488e1337 class=n-a></a><h3 class=section-title>SUB1 and SERA6</h3><p class="" id=d18488e1342>During asexual replication, the malaria parasite must exit the red blood cell before invading a new cell. This process, called egress, requires the rupture of both the parasitophorous vacuole membrane (PVM), which surrounds the parasite, and the red blood cell membrane (RBCM). Egress is protease dependent<sup><a href="#ref-99">99</a></sup>, and recently two proteasesSUB1 and SERA6were identified as mediators of PVM and RBCM rupture<sup><a href="#ref-98">98</a></sup>. SUB1, a serine protease, moves to the parasitophorous vacuole before egress<sup><a href="#ref-100">100</a><a href="#ref-104">104</a></sup> and cleaves multiple substrates<sup><a href="#ref-100">100</a>,<a href="#ref-103">103</a>,<a href="#ref-105">105</a><a href="#ref-107">107</a></sup>. One substrate cleaved by SUB1 is SERA6<sup><a href="#ref-108">108</a><a href="#ref-110">110</a></sup>, a putative cysteine protease, which requires proteolytic processing by SUB1 to function<sup><a href="#ref-98">98</a></sup>. <i>P. falciparum</i> parasites that lack SUB1 fail to rupture the PVM, thus stalling parasite development<sup><a href="#ref-98">98</a></sup>. Interestingly, parasites that lack SERA6 can rupture the PVM, but RBCM rupture does not occur<sup><a href="#ref-98">98</a></sup>. Therefore, SUB1 and SERA6 have distinct roles in parasite egress. Because SUB1 and SERA6 are essential for asexual blood-stage growth and orthologues are found in other <i>Plasmodium</i> species<sup><a href="#ref-98">98</a></sup>, compounds that inhibit these proteins may be useful in treating multiple types of malarial disease.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18488e1407>Discussion</h2><p class="" id=d18488e1410>Malaria continues to be a major global health concern. <i>Plasmodium</i> elimination will not be possible without substantial ongoing efforts, including diagnostic testing and treatment of confirmed and asymptomatic infections, mosquito vector control, preventative therapies, and surveillance systems. Although all of these areas of malaria control are crucial, antimalarial drug discovery is among the most pressing because of the continued spread of antimalarial resistance. The MMV has focused its efforts on developing drugs that treat disease, prevent transmission, and provide chemoprotection. This multifaceted approach to the antimalarial development pipeline provides assurance that new antimalarials will contribute to broad approaches of malaria control.</p><p class="" id=d18488e1416>Studies in basic parasite biology remain extremely important to elimination efforts. Although the current antimalarial compounds under development have great potential, malaria control efforts will benefit from continued dissection of parasite biology. Ideally, new compounds will target proteins and pathways that are essential for parasite growth and transmission with diverse mechanisms of action. New antimalarials will almost certainly be employed in combination therapeutics, combining molecules of different chemical classes and with diverse mechanisms of action to slow the development of multi-drug resistance. Novel drug targets will be uncovered through multiple approaches, such as large-scale genetic and resistance screens. A deeper understanding of essential parasite biology will also aid in other aspects of malaria control, including mosquito vector control, advancement of diagnostic tests, and development of preventative therapies. To date, <i>Plasmodium</i> has successfully adapted to sequential drug selective pressure in the field. However, the remarkable successes of recent efforts to develop new antimalarials and identify drug targets suggest an optimistic future in treatment of disease, prevention of transmission, and protection against infection.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d18488e1425>Abbreviations</h2><p class="" id=d18488e1428>49c, hydroxyl-ethyl-amine-based scaffold compound 49c; DHODH, dihydroorotate dehydrogenase; MMV, Medicines for Malaria Venture; PI4K, phosphatidylinositol 4-kinase; <i>Plasmo</i>GEM, <i>Plasmodium</i> Genetic Modification Project; PMI, plasmepsin I; PMIV, plasmepsin IV; PMIX, plasmepsin IX; PMX, plasmepsin X; PVM, parasitophorous vacuole membrane; RBCM, red blood cell membrane</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d18488e1 class=n-a></a><h2 class=main-title id=d18823>Competing interests</h2><p class=metadata-entry><a name=d18488e99 class=n-a></a><p id=d18488e100> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d18488e1 class=n-a></a><h2 class=main-title id=d18825>Grant information</h2><p>This work was supported by the National Institutes of Health (R01AI103280 and R21AI123808-01 to Audrey Odom John and T32AI007172-37 to Emily Mathews), the Childrens Discovery Institute of Washington University and St. Louis Childrens Hospital (Audrey Odom John), and the Burroughs Wellcome Fund (to Audrey Odom John).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d18488e1441 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d19222>References</h2><div class="section ref-list"><a name=d18488e1441 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d18488e1448 class=n-a></a>Laveran A: Un nouveau parasite trouv dans le sang de malades atteints de fivre palustre. Origine parasitaire des accidents de limpaludisme. <i>Bull Mm Soc Md Hpitaux Paris.</i> 1881; <b>17</b>: 158164. <a target=xrefwindow id=d18488e1456 href="https://books.google.co.in/books?id=_cCDtgAACAAJ&amp;source=gbs_navlinks_s">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d18488e1465 class=n-a></a>Manson P: SURGEON-MAJOR RONALD ROSS'S RECENT INVESTIGATIONS on the MOSQUITO-MALARIA THEORY. <i>Br Med J.</i> 1898; <b>1</b>(1995): 15757. <a target=xrefwindow id=d18488e1473 href="http://www.ncbi.nlm.nih.gov/pubmed/20757898">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1476 href="http://dx.doi.org/10.1136/bmj.1.1955.1575">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1479 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2411754">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d18488e1488 class=n-a></a>Ross R: The role of the mosquito in the evolution of the malarial parasite: the recent researches of Surgeon-Major Ronald Ross, I.M.S. 1898. <i>Yale J Biol Med.</i> 2002; <b>75</b>(2): 1035. <a target=xrefwindow id=d18488e1496 href="http://www.ncbi.nlm.nih.gov/pubmed/12230308">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1499 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2588727">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d18488e1508 class=n-a></a>Golgi C: Sul infezione malarica. <i>Arch Sci Med Torino.</i> 1886; <b>10</b>: 109135.</span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d18488e1523 class=n-a></a>Golgi C: Sul ciclo evolutivo dei parassiti malarici nella febbre terzana: diagnosi differenziale tra i parassiti endoglobulari malarici della terzana e quelli della quartana. <i>Arch Sci Med Torino.</i> 1889; <b>13</b>: 173196.</span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d18488e1539 class=n-a></a>Grassi B, Bignami A, Bastianelli G: Ulteriore ricerche sul ciclo dei parassiti malarici umani sul corpo del zanzarone. <i>Atti R Accad Lincei.</i> 1899; <b>8</b>(2128).</span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d18488e1554 class=n-a></a>World Health Organization: World Malaria Report 2017. Geneva; licence: CC BY-NC-SA 3.0 IGO. 2017. <a target=xrefwindow id=d18488e1556 href="http://apps.who.int/iris/bitstream/handle/10665/259492/9789241565523-eng.pdf;jsessionid=67832E4FBDD37339E5EDA8553BE2003D?sequence=1">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d18488e1565 class=n-a></a>Coatney GR: Pitfalls in a Discovery: The Chronicle of Chloroquine. <i>Am J Trop Med Hyg.</i> 1963; <b>12</b>: 1218. <a target=xrefwindow id=d18488e1573 href="http://www.ncbi.nlm.nih.gov/pubmed/14021822">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1576 href="http://dx.doi.org/10.4269/ajtmh.1963.12.121">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d18488e1585 class=n-a></a>Ridley RG: Medical need, scientific opportunity and the drive for antimalarial drugs. <i>Nature.</i> 2002; <b>415</b>(6872): 68693. <a target=xrefwindow id=d18488e1593 href="http://www.ncbi.nlm.nih.gov/pubmed/11832957">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1596 href="http://dx.doi.org/10.1038/415686a">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d18488e1605 class=n-a></a>Baird JK: Effectiveness of antimalarial drugs. <i>N Engl J Med.</i> 2005; <b>352</b>(15): 156577. <a target=xrefwindow id=d18488e1613 href="http://www.ncbi.nlm.nih.gov/pubmed/15829537">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1616 href="http://dx.doi.org/10.1056/NEJMra043207">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d18488e1625 class=n-a></a>Huang F, Takala-Harrison S, Jacob CG, <i> et al.</i>: A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of <i>Plasmodium falciparum</i> Following Artemisinin Treatment. <i>J Infect Dis.</i> 2015; <b>212</b>(10): 162935. <a target=xrefwindow id=d18488e1639 href="http://www.ncbi.nlm.nih.gov/pubmed/25910630">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1643 href="http://dx.doi.org/10.1093/infdis/jiv249">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4621243">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d18488e1656 class=n-a></a>Amaratunga C, Sreng S, Suon S, <i> et al.</i>: Artemisinin-resistant <i>Plasmodium falciparum</i> in Pursat province, western Cambodia: a parasite clearance rate study. <i>Lancet Infect Dis.</i> 2012; <b>12</b>(11): 8518. <a target=xrefwindow id=d18488e1670 href="http://www.ncbi.nlm.nih.gov/pubmed/22940027">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1674 href="http://dx.doi.org/10.1016/S1473-3099(12)70181-0">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3786328">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14267067"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e1686 class=n-a></a>Phyo AP, Nkhoma S, Stepniewska K, <i> et al.</i>: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. <i>Lancet.</i> 2012; <b>379</b>(9830): 19606. <a target=xrefwindow id=d18488e1697 href="http://www.ncbi.nlm.nih.gov/pubmed/22484134">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1700 href="http://dx.doi.org/10.1016/S0140-6736(12)60484-X">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1704 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3525980">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14267067">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1166410"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e1717 class=n-a></a>Dondorp AM, Nosten F, Yi P, <i> et al.</i>: Artemisinin resistance in <i>Plasmodium falciparum</i> malaria. <i>N Engl J Med.</i> 2009; <b>361</b>(5): 45567. <a target=xrefwindow id=d18488e1731 href="http://www.ncbi.nlm.nih.gov/pubmed/19641202">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1735 href="http://dx.doi.org/10.1056/NEJMoa0808859">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1738 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3495232">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1166410">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d18488e1751 class=n-a></a>Thriemer K, Hong VN, Rosanas-Urgell A, <i> et al.</i>: Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in <i>Plasmodium falciparum</i> malaria patients in central Vietnam. <i>Antimicrob Agents Chemother.</i> 2014; <b>58</b>(12): 704955. <a target=xrefwindow id=d18488e1765 href="http://www.ncbi.nlm.nih.gov/pubmed/25224002">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1769 href="http://dx.doi.org/10.1128/AAC.02746-14">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1772 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4249535">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726190107"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e1781 class=n-a></a>MalariaGEN Plasmodium falciparum Community Project: Genomic epidemiology of artemisinin resistant malaria. <i>eLife.</i> 2016; pii: e08714. <a target=xrefwindow id=d18488e1786 href="http://www.ncbi.nlm.nih.gov/pubmed/26943619">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1789 href="http://dx.doi.org/10.7554/eLife.08714">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4786412">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726190107">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d18488e1805 class=n-a></a>Kyaw MP, Nyunt MH, Chit K, <i> et al.</i>: Reduced susceptibility of <i>Plasmodium falciparum</i> to artesunate in southern Myanmar. <i>PLoS One.</i> 2013; <b>8</b>(3): e57689. <a target=xrefwindow id=d18488e1819 href="http://www.ncbi.nlm.nih.gov/pubmed/23520478">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1823 href="http://dx.doi.org/10.1371/journal.pone.0057689">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3592920">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d18488e1835 class=n-a></a>Hien TT, Thuy-Nhien NT, Phu NH, <i> et al.</i>: <i>In vivo</i> susceptibility of <i>Plasmodium falciparum</i> to artesunate in Binh Phuoc Province, Vietnam. <i>Malar J.</i> 2012; <b>11</b>: 355. <a target=xrefwindow id=d18488e1853 href="http://www.ncbi.nlm.nih.gov/pubmed/23101492">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1856 href="http://dx.doi.org/10.1186/1475-2875-11-355">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1859 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3504531">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d18488e1868 class=n-a></a>Leang R, Taylor WR, Bouth DM, <i> et al.</i>: Evidence of <i>Plasmodium falciparum</i> Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment. <i>Antimicrob Agents Chemother.</i> 2015; <b>59</b>(8): 471926. <a target=xrefwindow id=d18488e1882 href="http://www.ncbi.nlm.nih.gov/pubmed/26014949">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1886 href="http://dx.doi.org/10.1128/AAC.00835-15">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1889 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4505193">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d18488e1898 class=n-a></a>Dondorp AM, Fairhurst RM, Slutsker L, <i> et al.</i>: The threat of artemisinin-resistant malaria. <i>N Engl J Med.</i> 2011; <b>365</b>(12): 10735. <a target=xrefwindow id=d18488e1909 href="http://www.ncbi.nlm.nih.gov/pubmed/21992120">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1912 href="http://dx.doi.org/10.1056/NEJMp1108322">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1916 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3733336">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d18488e1925 class=n-a></a>Noedl H, Se Y, Schaecher K, <i> et al.</i>: Evidence of artemisinin-resistant malaria in western Cambodia. <i>N Engl J Med.</i> 2008; <b>359</b>(24): 261920. <a target=xrefwindow id=d18488e1936 href="http://www.ncbi.nlm.nih.gov/pubmed/19064625">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1939 href="http://dx.doi.org/10.1056/NEJMc0805011">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718210899"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e1948 class=n-a></a>Ariey F, Witkowski B, Amaratunga C, <i> et al.</i>: A molecular marker of artemisinin-resistant <i>Plasmodium falciparum</i> malaria. <i>Nature.</i> 2014; <b>505</b>(7481): 505. <a target=xrefwindow id=d18488e1962 href="http://www.ncbi.nlm.nih.gov/pubmed/24352242">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1966 href="http://dx.doi.org/10.1038/nature12876">Publisher Full Text </a> | <a target=xrefwindow id=d18488e1969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5007947">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718210899">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5063956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e1982 class=n-a></a>Rottmann M, McNamara C, Yeung BK, <i> et al.</i>: Spiroindolones, a potent compound class for the treatment of malaria. <i>Science.</i> 2010; <b>329</b>(5996): 117580. <a target=xrefwindow id=d18488e1993 href="http://www.ncbi.nlm.nih.gov/pubmed/20813948">PubMed Abstract </a> | <a target=xrefwindow id=d18488e1996 href="http://dx.doi.org/10.1126/science.1193225">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2000 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3050001">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5063956">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d18488e2014 class=n-a></a>Coteron JM, Marco M, Esquivias J, <i> et al.</i>: Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent <i>Plasmodium falciparum</i> dihydroorotate dehydrogenase inhibitors with clinical candidate potential. <i>J Med Chem.</i> 2011; <b>54</b>(15): 554061. <a target=xrefwindow id=d18488e2028 href="http://www.ncbi.nlm.nih.gov/pubmed/21696174">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2032 href="http://dx.doi.org/10.1021/jm200592f">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2035 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3156099">Free Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d18488e2044 class=n-a></a>LaMonte G, Lim MY, Wree M, <i> et al.</i>: Mutations in the <i>Plasmodium falciparum</i> Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance. <i>mBio.</i> 2016; <b>7</b>(4): pii: e00696-16. <a target=xrefwindow id=d18488e2058 href="http://www.ncbi.nlm.nih.gov/pubmed/27381290">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2062 href="http://dx.doi.org/10.1128/mBio.00696-16">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2065 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4958248">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d18488e2074 class=n-a></a>Lim MY, LaMonte G, Lee MC, <i> et al.</i>: UDP-galactose and acetyl-CoA transporters as <i>Plasmodium</i> multidrug resistance genes. <i>Nat Microbiol.</i> 2016; <b>1</b>; 16166. <a target=xrefwindow id=d18488e2088 href="http://www.ncbi.nlm.nih.gov/pubmed/27642791">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2092 href="http://dx.doi.org/10.1038/nmicrobiol.2016.166">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2095 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5575994">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d18488e2104 class=n-a></a>Paquet T, Le Manach C, Cabrera DG, <i> et al.</i>: Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinase. <i>Sci Transl Med.</i> 2017; <b>9</b>(387): pii: eaad9735. <a target=xrefwindow id=d18488e2118 href="http://www.ncbi.nlm.nih.gov/pubmed/28446690">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2122 href="http://dx.doi.org/10.1126/scitranslmed.aad9735">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2125 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5731459">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d18488e2134 class=n-a></a>Jimnez-Daz MB, Ebert D, Salinas Y, <i> et al.</i>: (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of <i>Plasmodium</i>. <i>Proc Natl Acad Sci U S A.</i> 2014; <b>111</b>(50): E5455-62. <a target=xrefwindow id=d18488e2148 href="http://www.ncbi.nlm.nih.gov/pubmed/25453091">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2152 href="http://dx.doi.org/10.1073/pnas.1414221111">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2155 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4273362">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725246790"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2164 class=n-a></a>Vaidya AB, Morrisey JM, Zhang Z, <i> et al.</i>: Pyrazoleamide compounds are potent antimalarials that target Na<sup>+</sup> homeostasis in intraerythrocytic <i>Plasmodium falciparum</i>. <i>Nat Commun.</i> 2014; <b>5</b>: 5521. <a target=xrefwindow id=d18488e2182 href="http://www.ncbi.nlm.nih.gov/pubmed/25422853">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2185 href="http://dx.doi.org/10.1038/ncomms6521">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2188 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4263321">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725246790">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727500204"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2202 class=n-a></a>Straimer J, Gndig NF, Stokes BH, <i> et al.</i>: <i>Plasmodium falciparum</i> K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness <i>In Vitro</i>. <i>mBio.</i> 2017; <b>8</b>(2): pii: e00172-17. <a target=xrefwindow id=d18488e2220 href="http://www.ncbi.nlm.nih.gov/pubmed/28400526">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2223 href="http://dx.doi.org/10.1128/mBio.00172-17">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2226 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5388803">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727500204">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726717596"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2239 class=n-a></a>Siriwardana A, Iyengar K, Roepe PD: Endoperoxide Drug Cross-Resistance Patterns for <i>Plasmodium falciparum</i> Exhibiting an Artemisinin Delayed-Clearance Phenotype. <i>Antimicrob Agents Chemother.</i> 2016; <b>60</b>(11): 69526. <a target=xrefwindow id=d18488e2250 href="http://www.ncbi.nlm.nih.gov/pubmed/27600038">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2253 href="http://dx.doi.org/10.1128/AAC.00857-16">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2257 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5075116">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726717596">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726345441"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2270 class=n-a></a>Yang T, Xie SC, Cao P, <i> et al.</i>: Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant <i>Plasmodium falciparum</i> Strains. <i>Antimicrob Agents Chemother.</i> 2016; <b>60</b>(8): 450110. <a target=xrefwindow id=d18488e2284 href="http://www.ncbi.nlm.nih.gov/pubmed/27161632">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2288 href="http://dx.doi.org/10.1128/AAC.00574-16">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2291 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4958167">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726345441">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727244947"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2304 class=n-a></a>Baumgrtner F, Jourdan J, Scheurer C, <i> et al.</i>: <i>In vitro</i> activity of anti-malarial ozonides against an artemisinin-resistant isolate. <i>Malar J.</i> 2017; <b>16</b>(1): 45. <a target=xrefwindow id=d18488e2318 href="http://www.ncbi.nlm.nih.gov/pubmed/28122617">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2322 href="http://dx.doi.org/10.1186/s12936-017-1696-0">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5267415">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727244947">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11732966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2338 class=n-a></a>Charman SA, Arbe-Barnes S, Bathurst IC, <i> et al.</i>: Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(11): 44005. <a target=xrefwindow id=d18488e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/21300861">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2352 href="http://dx.doi.org/10.1073/pnas.1015762108">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2356 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3060245">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11732966">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d18488e2369 class=n-a></a>Bolscher JM, Koolen KM, van Gemert GJ, <i> et al.</i>: A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. <i>J Antimicrob Chemother.</i> 2015; <b>70</b>(5): 135766. <a target=xrefwindow id=d18488e2380 href="http://www.ncbi.nlm.nih.gov/pubmed/25667405">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2383 href="http://dx.doi.org/10.1093/jac/dkv003">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726407436"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2393 class=n-a></a>McCarthy JS, Baker M, O'Rourke P, <i> et al.</i>: Efficacy of OZ439 (artefenomel) against early <i>Plasmodium falciparum</i> blood-stage malaria infection in healthy volunteers. <i>J Antimicrob Chemother.</i> 2016; <b>71</b>(9): 26207. <a target=xrefwindow id=d18488e2407 href="http://www.ncbi.nlm.nih.gov/pubmed/27272721">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2411 href="http://dx.doi.org/10.1093/jac/dkw174">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2414 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4992851">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726407436">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d18488e2427 class=n-a></a>Daher W, Biot C, Fandeur T, <i> et al.</i>: Assessment of <i>Plasmodium falciparum</i> resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. <i>Malar J.</i> 2006; <b>5</b>: 11. <a target=xrefwindow id=d18488e2441 href="http://www.ncbi.nlm.nih.gov/pubmed/16464254">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2445 href="http://dx.doi.org/10.1186/1475-2875-5-11">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2448 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1395321">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d18488e2457 class=n-a></a>Henry M, Briolant S, Fontaine A, <i> et al.</i>: <i>In vitro</i> activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in <i>Plasmodium falciparum</i>. <i>Antimicrob Agents Chemother.</i> 2008; <b>52</b>(8): 27559. <a target=xrefwindow id=d18488e2475 href="http://www.ncbi.nlm.nih.gov/pubmed/18505855">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2478 href="http://dx.doi.org/10.1128/AAC.00060-08">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2493139">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d18488e2490 class=n-a></a>Barends M, Jaidee A, Khaohirun N, <i> et al.</i>: <i>In vitro</i> activity of ferroquine (SSR 97193) against <i>Plasmodium falciparum</i> isolates from the Thai-Burmese border. <i>Malar J.</i> 2007; <b>6</b>: 81. <a target=xrefwindow id=d18488e2508 href="http://www.ncbi.nlm.nih.gov/pubmed/17597537">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2511 href="http://dx.doi.org/10.1186/1475-2875-6-81">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2514 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1934364">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d18488e2523 class=n-a></a>Held J, Supan C, Salazar CL, <i> et al.</i>: Ferroquine and artesunate in African adults and children with <i>Plasmodium falciparum</i> malaria: A phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. <i>Lancet Infect Dis.</i> 2015; <b>15</b>(12): 140919. <a target=xrefwindow id=d18488e2537 href="http://www.ncbi.nlm.nih.gov/pubmed/26342427">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2541 href="http://dx.doi.org/10.1016/S1473-3099(15)00079-1">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d18488e2550 class=n-a></a>Wells TN, Hooft van Huijsduijnen R: Ferroquine: Welcome to the next generation of antimalarials. <i>Lancet Infect Dis.</i> 2015; <b>15</b>: 13656. <a target=xrefwindow id=d18488e2558 href="http://www.ncbi.nlm.nih.gov/pubmed/26342426">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2561 href="http://dx.doi.org/10.1016/S1473-3099(15)00148-6">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729511745"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2571 class=n-a></a>McCarthy JS, Rckle T, Djeriou E, <i> et al.</i>: A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early <i>Plasmodium falciparum</i> in an induced blood-stage malaria infection study. <i>Malar J.</i> 2016; <b>15</b>(1): 469. <a target=xrefwindow id=d18488e2585 href="http://www.ncbi.nlm.nih.gov/pubmed/27624471">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2589 href="http://dx.doi.org/10.1186/s12936-016-1511-3">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2592 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5022189">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729511745">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d18488e2605 class=n-a></a>Patel V, Booker M, Kramer M, <i> et al.</i>: Identification and characterization of small molecule inhibitors of <i>Plasmodium falciparum</i> dihydroorotate dehydrogenase. <i>J Biol Chem.</i> 2008; <b>283</b>: 3507885. <a target=xrefwindow id=d18488e2619 href="http://www.ncbi.nlm.nih.gov/pubmed/18842591">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2623 href="http://dx.doi.org/10.1074/jbc.M804990200">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2626 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2596402">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d18488e2635 class=n-a></a>Baldwin J, Michnoff CH, Malmquist NA, <i> et al.</i>: High-throughput screening for potent and selective inhibitors of <i>Plasmodium falciparum</i> dihydroorotate dehydrogenase. <i>J Biol Chem.</i> 2005; <b>280</b>(23): 2184753. <a target=xrefwindow id=d18488e2649 href="http://www.ncbi.nlm.nih.gov/pubmed/15795226">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2653 href="http://dx.doi.org/10.1074/jbc.M501100200">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d18488e2662 class=n-a></a>Phillips MA, Lotharius J, Marsh K, <i> et al.</i>: A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. <i>Sci Transl Med.</i> 2015; <b>7</b>(296): 296ra111. <a target=xrefwindow id=d18488e2673 href="http://www.ncbi.nlm.nih.gov/pubmed/26180101">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2676 href="http://dx.doi.org/10.1126/scitranslmed.aaa6645">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2680 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4539048">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727467445"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2689 class=n-a></a>Sulyok M, Rckle T, Roth A, <i> et al.</i>: DSM265 for <i>Plasmodium falciparum</i> chemoprophylaxis: A randomised, double blinded, phase 1 trial with controlled human malaria infection. <i>Lancet Infect Dis.</i> 2017; <b>17</b>(6): 63644. <a target=xrefwindow id=d18488e2703 href="http://www.ncbi.nlm.nih.gov/pubmed/28363637">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2707 href="http://dx.doi.org/10.1016/S1473-3099(17)30139-1">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5446410">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727467445">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732240504"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2723 class=n-a></a>Murphy SC, Duke ER, Shipman KJ, <i> et al.</i>: A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic <i>Plasmodium falciparum</i> Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation. <i>J Infect Dis.</i> 2018; <b>217</b>(5): 693702. <a target=xrefwindow id=d18488e2737 href="http://www.ncbi.nlm.nih.gov/pubmed/29216395">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2741 href="http://dx.doi.org/10.1093/infdis/jix613">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2744 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5853383">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732240504">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d18488e2758 class=n-a></a>Yeung BK, Zou B, Rottmann M, <i> et al.</i>: Spirotetrahydro beta-carbolines (spiroindolones): a new class of potent and orally efficacious compounds for the treatment of malaria. <i>J Med Chem.</i> 2010; <b>53</b>(14): 515564. <a target=xrefwindow id=d18488e2769 href="http://www.ncbi.nlm.nih.gov/pubmed/20568778">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2772 href="http://dx.doi.org/10.1021/jm100410f">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718512040"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2781 class=n-a></a>White NJ, Pukrittayakamee S, Phyo AP, <i> et al.</i>: Spiroindolone KAE609 for falciparum and vivax malaria. <i>N Engl J Med.</i> 2014; <b>371</b>(5): 40310. <a target=xrefwindow id=d18488e2792 href="http://www.ncbi.nlm.nih.gov/pubmed/25075833">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2795 href="http://dx.doi.org/10.1056/NEJMoa1315860">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4143746">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718512040">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d18488e2812 class=n-a></a>Kirk K: Ion Regulation in the Malaria Parasite. <i>Annu Rev Microbiol.</i> 2015; <b>69</b>: 34159. <a target=xrefwindow id=d18488e2820 href="http://www.ncbi.nlm.nih.gov/pubmed/26488277">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2823 href="http://dx.doi.org/10.1146/annurev-micro-091014-104506">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d18488e2832 class=n-a></a>Spillman NJ, Allen RJ, McNamara CW, <i> et al.</i>: Na<sup>+</sup> regulation in the malaria parasite <i>Plasmodium falciparum</i> involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. <i>Cell Host Microbe.</i> 2013; <b>13</b>(2): 22737. <a target=xrefwindow id=d18488e2850 href="http://www.ncbi.nlm.nih.gov/pubmed/23414762">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2853 href="http://dx.doi.org/10.1016/j.chom.2012.12.006">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2856 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3574224">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d18488e2865 class=n-a></a>van Pelt-Koops JC, Pett HE, Graumans W, <i> et al.</i>: The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks <i>Plasmodium falciparum</i> transmission to anopheles mosquito vector. <i>Antimicrob Agents Chemother.</i> 2012; <b>56</b>(7): 35448. <a target=xrefwindow id=d18488e2879 href="http://www.ncbi.nlm.nih.gov/pubmed/22508309">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2883 href="http://dx.doi.org/10.1128/AAC.06377-11">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2886 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3393464">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d18488e2895 class=n-a></a>Flannery EL, McNamara CW, Kim SW, <i> et al.</i>: Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials. <i>ACS Chem Biol.</i> 2015; <b>10</b>(2): 41320. <a target=xrefwindow id=d18488e2906 href="http://www.ncbi.nlm.nih.gov/pubmed/25322084">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2909 href="http://dx.doi.org/10.1021/cb500616x">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2913 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4340351">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d18488e2923 class=n-a></a>Lehane AM, Ridgway MC, Baker E, <i> et al.</i>: Diverse chemotypes disrupt ion homeostasis in the Malaria parasite. <i>Mol Microbiol.</i> 2014; <b>94</b>(2): 32739. <a target=xrefwindow id=d18488e2934 href="http://www.ncbi.nlm.nih.gov/pubmed/25145582">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2937 href="http://dx.doi.org/10.1111/mmi.12765">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13405001"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e2946 class=n-a></a>Meister S, Plouffe DM, Kuhen KL, <i> et al.</i>: Imaging of <i>Plasmodium</i> liver stages to drive next-generation antimalarial drug discovery. <i>Science.</i> 2011; <b>334</b>(6061): 13727. <a target=xrefwindow id=d18488e2960 href="http://www.ncbi.nlm.nih.gov/pubmed/22096101">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2964 href="http://dx.doi.org/10.1126/science.1211936">Publisher Full Text </a> | <a target=xrefwindow id=d18488e2967 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3473092">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13405001">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d18488e2980 class=n-a></a>Wu T, Nagle A, Kuhen K, <i> et al.</i>: Imidazolopiperazines: hit to lead optimization of new antimalarial agents. <i>J Med Chem.</i> 2011; <b>54</b>(14): 511630. <a target=xrefwindow id=d18488e2991 href="http://www.ncbi.nlm.nih.gov/pubmed/21644570">PubMed Abstract </a> | <a target=xrefwindow id=d18488e2994 href="http://dx.doi.org/10.1021/jm2003359">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d18488e3003 class=n-a></a>Kuhen KL, Chatterjee AK, Rottmann M, <i> et al.</i>: KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. <i>Antimicrob Agents Chemother.</i> 2014; <b>58</b>(9): 50607. <a target=xrefwindow id=d18488e3014 href="http://www.ncbi.nlm.nih.gov/pubmed/24913172">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3017 href="http://dx.doi.org/10.1128/AAC.02727-13">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3021 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4135840">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d18488e3030 class=n-a></a>Younis Y, Douelle F, Feng TS, <i> et al.</i>: 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. <i>J Med Chem.</i> 2012; <b>55</b>(7): 347987. <a target=xrefwindow id=d18488e3041 href="http://www.ncbi.nlm.nih.gov/pubmed/22390538">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3044 href="http://dx.doi.org/10.1021/jm3001373">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718190118"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3053 class=n-a></a>McNamara CW, Lee MC, Lim CS, <i> et al.</i>: Targeting <i>Plasmodium</i> PI(4)K to eliminate malaria. <i>Nature.</i> 2013; <b>504</b>(7479): 24853. <a target=xrefwindow id=d18488e3067 href="http://www.ncbi.nlm.nih.gov/pubmed/24284631">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3071 href="http://dx.doi.org/10.1038/nature12782">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3074 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3940870">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718190118">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725878141"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3088 class=n-a></a>Beck HP, Wampfler R, Carter N, <i> et al.</i>: Estimation of the Antirelapse Efficacy of Tafenoquine, Using <i>Plasmodium vivax</i> Genotyping. <i>J Infect Dis.</i> 2016; <b>213</b>(5): 7949. <a target=xrefwindow id=d18488e3102 href="http://www.ncbi.nlm.nih.gov/pubmed/26500351">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3106 href="http://dx.doi.org/10.1093/infdis/jiv508">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3109 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4747625">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725878141">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727846714"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3122 class=n-a></a>Rueangweerayut R, Bancone G, Harrell EJ, <i> et al.</i>: Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (<i>G6PD Mahidol</i> Variant) versus G6PD-Normal Volunteers. <i>Am J Trop Med Hyg.</i> 2017; <b>97</b>(3): 70211. <a target=xrefwindow id=d18488e3136 href="http://www.ncbi.nlm.nih.gov/pubmed/28749773">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3140 href="http://dx.doi.org/10.4269/ajtmh.16-0779">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3143 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5590573">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727846714">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d18488e3156 class=n-a></a>ALVING AS, JOHNSON CF, TARLOV AR, <i> et al.</i>: Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. <i>Bull World Health Organ.</i> 1960; <b>22</b>: 62131. <a target=xrefwindow id=d18488e3167 href="http://www.ncbi.nlm.nih.gov/pubmed/13793053">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3170 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2555355">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733085641"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3179 class=n-a></a>Watson J, Taylor WRJ, Bancone G, <i> et al.</i>: Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. <i>PLoS Negl Trop Dis.</i> 2018; <b>12</b>(4): e0006440. <a target=xrefwindow id=d18488e3190 href="http://www.ncbi.nlm.nih.gov/pubmed/29677199">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3193 href="http://dx.doi.org/10.1371/journal.pntd.0006440">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3197 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5931686">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733085641">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d18488e3210 class=n-a></a>Schwach F, Bushell E, Gomes AR, <i> et al.</i>: <i>Plasmo</i>GEM, a database supporting a community resource for large-scale experimental genetics in malaria parasites. <i>Nucleic Acids Res.</i> 2015; <b>43</b>(Database issue): D117682. <a target=xrefwindow id=d18488e3224 href="http://www.ncbi.nlm.nih.gov/pubmed/25593348">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3228 href="http://dx.doi.org/10.1093/nar/gku1143">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3231 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4383951">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727807130"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3240 class=n-a></a>Bushell E, Gomes AR, Sanderson T, <i> et al.</i>: Functional Profiling of a <i>Plasmodium</i> Genome Reveals an Abundance of Essential Genes. <i>Cell.</i> 2017; <b>170</b>(2): 260272.e8. <a target=xrefwindow id=d18488e3254 href="http://www.ncbi.nlm.nih.gov/pubmed/28708996">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3258 href="http://dx.doi.org/10.1016/j.cell.2017.06.030">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3261 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5509546">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727807130">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733159490"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3275 class=n-a></a>Zhang M, Wang C, Otto TD, <i> et al.</i>: Uncovering the essential genes of the human malaria parasite <i>Plasmodium falciparum</i> by saturation mutagenesis. <i>Science.</i> 2018; <b>360</b>(6388): pii: eaap7847. <a target=xrefwindow id=d18488e3289 href="http://www.ncbi.nlm.nih.gov/pubmed/29724925">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3293 href="http://dx.doi.org/10.1126/science.aap7847">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733159490">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d18488e3306 class=n-a></a>Bronner IF, Otto TD, Zhang M, <i> et al.</i>: Quantitative insertion-site sequencing (QIseq) for high throughput phenotyping of transposon mutants. <i>Genome Res.</i> 2016; <b>26</b>(7): 9809. <a target=xrefwindow id=d18488e3317 href="http://www.ncbi.nlm.nih.gov/pubmed/27197223">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3320 href="http://dx.doi.org/10.1101/gr.200279.115">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3324 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4937560">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725961145"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3333 class=n-a></a>Hart T, Chandrashekhar M, Aregger M, <i> et al.</i>: High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities. <i>Cell.</i> 2015; <b>163</b>(6): 151526. <a target=xrefwindow id=d18488e3344 href="http://www.ncbi.nlm.nih.gov/pubmed/26627737">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3347 href="http://dx.doi.org/10.1016/j.cell.2015.11.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725961145">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d18488e3360 class=n-a></a>Flannery EL, Fidock DA, Winzeler EA: Using genetic methods to define the targets of compounds with antimalarial activity. <i>J Med Chem.</i> 2013; <b>56</b>(20): 776171. <a target=xrefwindow id=d18488e3368 href="http://www.ncbi.nlm.nih.gov/pubmed/23927658">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3371 href="http://dx.doi.org/10.1021/jm400325j">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3374 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3880619">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732450333"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3383 class=n-a></a>Cowell AN, Istvan ES, Lukens AK, <i> et al.</i>: Mapping the malaria parasite druggable genome by using <i>in vitro</i> evolution and chemogenomics. <i>Science.</i> 2018; <b>359</b>(6372): 1919. <a target=xrefwindow id=d18488e3397 href="http://www.ncbi.nlm.nih.gov/pubmed/29326268">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3401 href="http://dx.doi.org/10.1126/science.aan4472">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3404 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5925756">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732450333">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732041165"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3417 class=n-a></a>Pino P, Caldelari R, Mukherjee B, <i> et al.</i>: A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress. <i>Science.</i> 2017; <b>358</b>(6362): 5228. <a target=xrefwindow id=d18488e3428 href="http://www.ncbi.nlm.nih.gov/pubmed/29074775">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3431 href="http://dx.doi.org/10.1126/science.aaf8675">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3435 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5730047">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732041165">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732041166"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3449 class=n-a></a>Nasamu AS, Glushakova S, Russo I, <i> et al.</i>: Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion. <i>Science.</i> 2017; <b>358</b>(6362): 51822. <a target=xrefwindow id=d18488e3460 href="http://www.ncbi.nlm.nih.gov/pubmed/29074774">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3463 href="http://dx.doi.org/10.1126/science.aan1478">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3467 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5928414">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732041166">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d18488e3480 class=n-a></a>Bhaumik P, Gustchina A, Wlodawer A: Structural studies of vacuolar plasmepsins. <i>Biochim Biophys Acta.</i> 2012; <b>1824</b>(1): 20723. <a target=xrefwindow id=d18488e3488 href="http://www.ncbi.nlm.nih.gov/pubmed/21540129">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3491 href="http://dx.doi.org/10.1016/j.bbapap.2011.04.008">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3494 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3154504">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d18488e3503 class=n-a></a>Meyers MJ, Goldberg DE: Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts. <i>CTMC.</i> 2012; <b>12</b>(5): 44555. <a target=xrefwindow id=d18488e3511 href="http://www.ncbi.nlm.nih.gov/pubmed/22242846">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3514 href="http://dx.doi.org/10.2174/156802612799362959">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d18488e3523 class=n-a></a>Boss C, Richard-Bildstein S, Weller T, <i> et al.</i>: Inhibitors of the <i>Plasmodium falciparum</i> parasite aspartic protease plasmepsin II as potential antimalarial agents. <i>CMC.</i> 2003; <b>10</b>(11): 883907. <a target=xrefwindow id=d18488e3537 href="http://www.ncbi.nlm.nih.gov/pubmed/12678679">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3541 href="http://dx.doi.org/10.2174/0929867033457674">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d18488e3550 class=n-a></a>Rasina D, Otikovs M, Leitans J, <i> et al.</i>: Fragment-Based Discovery of 2-Aminoquinazolin-4(3<i>H</i>)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV. <i>J Med Chem.</i> 2016; <b>59</b>(1): 37487. <a target=xrefwindow id=d18488e3564 href="http://www.ncbi.nlm.nih.gov/pubmed/26670264">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3568 href="http://dx.doi.org/10.1021/acs.jmedchem.5b01558">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d18488e3577 class=n-a></a>Bonilla JA, Bonilla TD, Yowell CA, <i> et al.</i>: Critical roles for the digestive vacuole plasmepsins of <i>Plasmodium falciparum</i> in vacuolar function. <i>Mol Microbiol.</i> 2007; <b>65</b>(1): 6475. <a target=xrefwindow id=d18488e3591 href="http://www.ncbi.nlm.nih.gov/pubmed/17581121">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3595 href="http://dx.doi.org/10.1111/j.1365-2958.2007.05768.x">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d18488e3605 class=n-a></a>Banerjee R, Liu J, Beatty W, <i> et al.</i>: Four plasmepsins are active in the <i>Plasmodium falciparum</i> food vacuole, including a protease with an active-site histidine. <i>Proc Natl Acad Sci U S A.</i> 2002; <b>99</b>(2): 9905. <a target=xrefwindow id=d18488e3619 href="http://www.ncbi.nlm.nih.gov/pubmed/11782538">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3623 href="http://dx.doi.org/10.1073/pnas.022630099">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3626 href="http://www.ncbi.nlm.nih.gov/pmc/articles/117418">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d18488e3635 class=n-a></a>Ciana C, Siegrist R, Aissaoui H, <i> et al.</i>: Novel <i>in vivo</i> active anti-malarials based on a hydroxy-ethyl-amine scaffold. <i>Bioorg Med Chem Lett.</i> 2013; <b>23</b>(3): 65862. <a target=xrefwindow id=d18488e3649 href="http://www.ncbi.nlm.nih.gov/pubmed/23260352">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3653 href="http://dx.doi.org/10.1016/j.bmcl.2012.11.118">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3309957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3662 class=n-a></a>Guiguemde WA, Shelat AA, Bouck D, <i> et al.</i>: Chemical genetics of <i>Plasmodium falciparum</i>. <i>Nature.</i> 2010; <b>465</b>(7296): 3115. <a target=xrefwindow id=d18488e3676 href="http://www.ncbi.nlm.nih.gov/pubmed/20485428">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3680 href="http://dx.doi.org/10.1038/nature09099">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3683 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2874979">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3309957">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d18488e3696 class=n-a></a>Zhang B, Watts KM, Hodge D, <i> et al.</i>: A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling. <i>Biochemistry.</i> 2011; <b>50</b>(17): 35707. <a target=xrefwindow id=d18488e3707 href="http://www.ncbi.nlm.nih.gov/pubmed/21438569">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3710 href="http://dx.doi.org/10.1021/bi200113y">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3714 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3082593">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13169957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e3723 class=n-a></a>Yeh E, DeRisi JL: Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage <i>Plasmodium falciparum</i>. <i>PLoS Biol.</i> 2011; <b>9</b>(8): e1001138. <a target=xrefwindow id=d18488e3734 href="http://www.ncbi.nlm.nih.gov/pubmed/21912516">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3737 href="http://dx.doi.org/10.1371/journal.pbio.1001138">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3741 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3166167">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13169957">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d18488e3754 class=n-a></a>Jomaa H, Wiesner J, Sanderbrand S, <i> et al.</i>: Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs. <i>Science.</i> 1999; <b>285</b>(5433): 15736. <a target=xrefwindow id=d18488e3765 href="http://www.ncbi.nlm.nih.gov/pubmed/10477522">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3768 href="http://dx.doi.org/10.1126/science.285.5433.1573">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d18488e3778 class=n-a></a>Buckner FS, Eastman RT, Yokoyama K, <i> et al.</i>: Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis. <i>Curr Opin Investig Drugs.</i> 2005; <b>6</b>(8): 7917. <a target=xrefwindow id=d18488e3789 href="http://www.ncbi.nlm.nih.gov/pubmed/16121685">PubMed Abstract </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d18488e3798 class=n-a></a>Glenn MP, Chang SY, Hucke O, <i> et al.</i>: Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites. <i>Angew Chem Int Ed Engl.</i> 2005; <b>44</b>(31): 49036. <a target=xrefwindow id=d18488e3809 href="http://www.ncbi.nlm.nih.gov/pubmed/16007716">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3812 href="http://dx.doi.org/10.1002/anie.200500674">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d18488e3821 class=n-a></a>Glenn MP, Chang SY, Horny C, <i> et al.</i>: Structurally simple, potent, <i>Plasmodium</i> selective farnesyltransferase inhibitors that arrest the growth of malaria parasites. <i>J Med Chem.</i> 2006; <b>49</b>(19): 571027. <a target=xrefwindow id=d18488e3835 href="http://www.ncbi.nlm.nih.gov/pubmed/16970397">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3839 href="http://dx.doi.org/10.1021/jm060081v">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3842 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2728208">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d18488e3851 class=n-a></a>Nallan L, Bauer KD, Bendale P, <i> et al.</i>: Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. <i>J Med Chem.</i> 2005; <b>48</b>(11):370413. <a target=xrefwindow id=d18488e3862 href="http://www.ncbi.nlm.nih.gov/pubmed/15916422">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3865 href="http://dx.doi.org/10.1021/jm0491039">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d18488e3874 class=n-a></a>Howe R, Kelly M, Jimah J, <i> et al.</i>: Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in <i>Plasmodium falciparum</i>. <i>Eukaryot Cell.</i> 2013; <b>12</b>(2): 21523. <a target=xrefwindow id=d18488e3888 href="http://www.ncbi.nlm.nih.gov/pubmed/23223036">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3892 href="http://dx.doi.org/10.1128/EC.00073-12">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3895 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3571303">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d18488e3904 class=n-a></a>Chakrabarti D, Da Silva T, Barger J, <i> et al.</i>: Protein farnesyltransferase and protein prenylation in <i>Plasmodium falciparum</i>. <i>J Biol Chem.</i> 2002; <b>277</b>(44): 4206673. <a target=xrefwindow id=d18488e3918 href="http://www.ncbi.nlm.nih.gov/pubmed/12194969">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3922 href="http://dx.doi.org/10.1074/jbc.M202860200">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d18488e3932 class=n-a></a>Chakrabarti D, Azam T, DelVecchio C, <i> et al.</i>: Protein prenyl transferase activities of <i>Plasmodium falciparum</i>. <i>Mol Biochem Parasitol.</i> 1998; <b>94</b>(2): 17584. <a target=xrefwindow id=d18488e3946 href="http://www.ncbi.nlm.nih.gov/pubmed/9747968">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3950 href="http://dx.doi.org/10.1016/S0166-6851(98)00065-6">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d18488e3959 class=n-a></a>Gisselberg JE, Zhang L, Elias JE, <i> et al.</i>: The Prenylated Proteome of <i>Plasmodium falciparum</i> Reveals Pathogen-specific Prenylation Activity and Drug Mechanism-of-action. <i>Mol Cell Proteomics.</i> 2017; <b>16</b>(4 suppl 1): S54S64. <a target=xrefwindow id=d18488e3973 href="http://www.ncbi.nlm.nih.gov/pubmed/28040698">PubMed Abstract </a> | <a target=xrefwindow id=d18488e3977 href="http://dx.doi.org/10.1074/mcp.M116.064550">Publisher Full Text </a> | <a target=xrefwindow id=d18488e3980 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5393391">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d18488e3989 class=n-a></a>Suazo KF, Schaber C, Palsuledesai CC, <i> et al.</i>: Global proteomic analysis of prenylated proteins in <i>Plasmodium falciparum</i> using an alkyne-modified isoprenoid analogue. <i>Sci Rep.</i> 2016; <b>6</b>: 38615. <a target=xrefwindow id=d18488e4003 href="http://www.ncbi.nlm.nih.gov/pubmed/27924931">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4007 href="http://dx.doi.org/10.1038/srep38615">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4010 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5141570">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d18488e4019 class=n-a></a>Gomes AQ, Ali BR, Ramalho JS, <i> et al.</i>: Membrane targeting of Rab GTPases is influenced by the prenylation motif. <i>Mol Biol Cell.</i> 2003; <b>14</b>(5): 188299. <a target=xrefwindow id=d18488e4030 href="http://www.ncbi.nlm.nih.gov/pubmed/12802062">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4033 href="http://dx.doi.org/10.1091/mbc.e02-10-0639">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4037 href="http://www.ncbi.nlm.nih.gov/pmc/articles/165084">Free Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d18488e4046 class=n-a></a>Quevillon E, Spielmann T, Brahimi K, <i> et al.</i>: The <i>Plasmodium falciparum</i> family of Rab GTPases. <i>Gene.</i> 2003; <b>306</b>: 1325. <a target=xrefwindow id=d18488e4060 href="http://www.ncbi.nlm.nih.gov/pubmed/12657463">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4064 href="http://dx.doi.org/10.1016/S0378-1119(03)00381-0">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d18488e4073 class=n-a></a>Agop-Nersesian C, Naissant B, Ben Rached F, <i> et al.</i>: Rab11A-controlled assembly of the inner membrane complex is required for completion of apicomplexan cytokinesis. <i>PLoS Pathog.</i> 2009; <b>5</b>(1): e1000270. <a target=xrefwindow id=d18488e4084 href="http://www.ncbi.nlm.nih.gov/pubmed/19165333">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4087 href="http://dx.doi.org/10.1371/journal.ppat.1000270">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4091 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2622761">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718424874"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4101 class=n-a></a>Burke JE, Inglis AJ, Perisic O, <i> et al.</i>: Structures of PI4KIII complexes show simultaneous recruitment of Rab11 and its effectors. <i>Science.</i> 2014; <b>344</b>(6187): 10358. <a target=xrefwindow id=d18488e4112 href="http://www.ncbi.nlm.nih.gov/pubmed/24876499">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4115 href="http://dx.doi.org/10.1126/science.1253397">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4119 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4046302">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718424874">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727478309"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4132 class=n-a></a>Gomes AR, Ravenhall M, Benavente ED, <i> et al.</i>: Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes. <i>Int J Parasitol Drugs Drug Resist.</i> 2017; <b>7</b>(2): 17480. <a target=xrefwindow id=d18488e4143 href="http://www.ncbi.nlm.nih.gov/pubmed/28376349">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4146 href="http://dx.doi.org/10.1016/j.ijpddr.2017.03.001">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4150 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5379905">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727478309">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732736462"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4163 class=n-a></a>Thomas JA, Tan MSY, Bisson C, <i> et al.</i>: A protease cascade regulates release of the human malaria parasite <i>Plasmodium falciparum</i> from host red blood cells. <i>Nat Microbiol.</i> 2018; <b>3</b>(4): 44755. <a target=xrefwindow id=d18488e4177 href="http://www.ncbi.nlm.nih.gov/pubmed/29459732">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4181 href="http://dx.doi.org/10.1038/s41564-018-0111-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732736462">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d18488e4194 class=n-a></a>Blackman MJ: Malarial proteases and host cell egress: an 'emerging' cascade. <i>Cell Microbiol.</i> 2008; <b>10</b>(10): 192534. <a target=xrefwindow id=d18488e4202 href="http://www.ncbi.nlm.nih.gov/pubmed/18503638">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4205 href="http://dx.doi.org/10.1111/j.1462-5822.2008.01176.x">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4208 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2610400">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1098804"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4217 class=n-a></a>Yeoh S, O'Donnell RA, Koussis K, <i> et al.</i>: Subcellular discharge of a serine protease mediates release of invasive malaria parasites from host erythrocytes. <i>Cell.</i> 2007; <b>131</b>(6): 107283. <a target=xrefwindow id=d18488e4228 href="http://www.ncbi.nlm.nih.gov/pubmed/18083098">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4231 href="http://dx.doi.org/10.1016/j.cell.2007.10.049">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1098804">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d18488e4244 class=n-a></a>Collins CR, Hackett F, Strath M, <i> et al.</i>: Malaria parasite cGMP-dependent protein kinase regulates blood stage merozoite secretory organelle discharge and egress. <i>PLoS Pathog.</i> 2013; <b>9</b>(5): e1003344. <a target=xrefwindow id=d18488e4255 href="http://www.ncbi.nlm.nih.gov/pubmed/23675297">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4258 href="http://dx.doi.org/10.1371/journal.ppat.1003344">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4262 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3649973">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d18488e4272 class=n-a></a>Withers-Martinez C, Strath M, Hackett F, <i> et al.</i>: The malaria parasite egress protease SUB1 is a calcium-dependent redox switch subtilisin. <i>Nat Commun.</i> 2014; <b>5</b>: 3726. <a target=xrefwindow id=d18488e4283 href="http://www.ncbi.nlm.nih.gov/pubmed/24785947">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4286 href="http://dx.doi.org/10.1038/ncomms4726">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4290 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4024747">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d18488e4299 class=n-a></a>Das S, Hertrich N, Perrin AJ, <i> et al.</i>: Processing of <i>Plasmodium falciparum</i> Merozoite Surface Protein MSP1 Activates a Spectrin-Binding Function Enabling Parasite Egress from RBCs. <i>Cell Host Microbe.</i> 2015; <b>18</b>(4): 43344. <a target=xrefwindow id=d18488e4313 href="http://www.ncbi.nlm.nih.gov/pubmed/26468747">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4317 href="http://dx.doi.org/10.1016/j.chom.2015.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4320 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4608996">Free Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727407684"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4329 class=n-a></a>Hale VL, Watermeyer JM, Hackett F, <i> et al.</i>: Parasitophorous vacuole poration precedes its rupture and rapid host erythrocyte cytoskeleton collapse in <i>Plasmodium falciparum</i> egress. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(13): 343944. <a target=xrefwindow id=d18488e4343 href="http://www.ncbi.nlm.nih.gov/pubmed/28292906">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4347 href="http://dx.doi.org/10.1073/pnas.1619441114">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4350 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5380091">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727407684">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d18488e4363 class=n-a></a>Koussis K, Withers-Martinez C, Yeoh S, <i> et al.</i>: A multifunctional serine protease primes the malaria parasite for red blood cell invasion. <i>EMBO J.</i> 2009; <b>28</b>(6): 72535. <a target=xrefwindow id=d18488e4374 href="http://www.ncbi.nlm.nih.gov/pubmed/19214190">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4377 href="http://dx.doi.org/10.1038/emboj.2009.22">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4381 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2647770">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d18488e4390 class=n-a></a>Silmon de Monerri NC, Flynn HR, Campos MG, <i> et al.</i>: Global identification of multiple substrates for <i>Plasmodium falciparum</i> SUB1, an essential malarial processing protease. <i>Infect Immun.</i> 2011; <b>79</b>(3): 108697. <a target=xrefwindow id=d18488e4404 href="http://www.ncbi.nlm.nih.gov/pubmed/21220481">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4408 href="http://dx.doi.org/10.1128/IAI.00902-10">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3067499">Free Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727781576"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4420 class=n-a></a>Collins CR, Hackett F, Atid J, <i> et al.</i>: The <i>Plasmodium falciparum</i> pseudoprotease SERA5 regulates the kinetics and efficiency of malaria parasite egress from host erythrocytes. <i>PLoS Pathog.</i> 2017; <b>13</b>(7): e1006453. <a target=xrefwindow id=d18488e4434 href="http://www.ncbi.nlm.nih.gov/pubmed/28683142">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4438 href="http://dx.doi.org/10.1371/journal.ppat.1006453">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4441 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5500368">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727781576">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d18488e4455 class=n-a></a>Ruecker A, Shea M, Hackett F, <i> et al.</i>: Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte. <i>J Biol Chem.</i> 2012; <b>287</b>(45): 3794963. <a target=xrefwindow id=d18488e4466 href="http://www.ncbi.nlm.nih.gov/pubmed/22984267">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4469 href="http://dx.doi.org/10.1074/jbc.M112.400820">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4473 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3488066">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1010064"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d18488e4482 class=n-a></a>Miller SK, Good RT, Drew DR, <i> et al.</i>: A subset of <i>Plasmodium falciparum</i> SERA genes are expressed and appear to play an important role in the erythrocytic cycle. <i>J Biol Chem.</i> 2002; <b>277</b>(49): 4752432. <a target=xrefwindow id=d18488e4496 href="http://www.ncbi.nlm.nih.gov/pubmed/12228245">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4500 href="http://dx.doi.org/10.1074/jbc.M206974200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1010064">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d18488e4513 class=n-a></a>Thomas JA, Collins CR, Das S, <i> et al.</i>: Development and Application of a Simple Plaque Assay for the Human Malaria Parasite <i>Plasmodium falciparum</i>. <i>PLoS One.</i> 2016; <b>11</b>(6): e0157873. <a target=xrefwindow id=d18488e4527 href="http://www.ncbi.nlm.nih.gov/pubmed/27332706">PubMed Abstract </a> | <a target=xrefwindow id=d18488e4531 href="http://dx.doi.org/10.1371/journal.pone.0157873">Publisher Full Text </a> | <a target=xrefwindow id=d18488e4534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4917082">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 01 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1170/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1170/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA<br/> <sup>2</sup> Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA<br/> <p> <div class=margin-bottom> Emily S. Mathews <br/> <span>Roles: </span> Visualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Audrey R. Odom John <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1170/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 01 Aug 2018, 7:1170 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14874.1">https://doi.org/10.12688/f1000research.14874.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Mathews ES and Odom John AR. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=16190 data-id=14874 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14874.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1170/v1/pdf?article_uuid=48eadd62-9d39-4ddb-9854-5fe8cf2e6505" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14874.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Mathews ES and Odom John AR. Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1170 (<a href="https://doi.org/10.12688/f1000research.14874.1" target=_blank>https://doi.org/10.12688/f1000research.14874.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14874 id=mobile-track-article-signin-14874 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14874?target=/articles/7-1170/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16190 /> <input name=articleId type=hidden value=14874 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Kirsten Hanson</strong>, Department of Biology and the South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Emily Derbyshire</strong>, Department of Molecular Genetics and Microbiology, Duke University Medical Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 01 Aug 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1170/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1170/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=37156-36507></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=37157-36508></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1170/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>01 Aug 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Kirsten Hanson</strong>, Department of Biology and the South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Emily Derbyshire</strong>, Department of Molecular Genetics and Microbiology, Duke University Medical Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1170/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1170/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Tackling resistance: emerging antimalarials...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1170/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1170/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1170/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Mathews ES and Odom John AR');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1170/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1170",
            templates : {
                twitter : "Tackling resistance: emerging antimalarials and new parasite.... Mathews ES and Odom John AR, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1170/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14874/16190")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "16190");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "36507": 0,
                           "36508": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "4870f6a4-ec6f-4ec8-8362-6f280b07026e";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1170.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1170.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1170.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1170.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1170.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>